Header Logo

Connection

Pauline Merrill to Evidence-Based Medicine

This is a "connection" page, showing publications Pauline Merrill has written about Evidence-Based Medicine.
Connection Strength

0.033
  1. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016 Sep 17; 388(10050):1183-92.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.